The most recent expert consensus statement on genetic testing guidelines in channelopathies recommend comprehensive RYR2 and CASQ2 targeted CPVT genetic testing for patients with a clinical index of suspicion for CPVT based on clinical history, family history and development of electrocardiographic phenotype with provocative testing. The gene discussed is CASQ2; the disease is channelopathy.